Genome & Company (KOSDAQ:314130)
South Korea
· Delayed Price · Currency is KRW 2,270.00
-130.00 (-5.42%)
At close: Mar 28, 2025, 3:30 PM KST
-50.27% (1Y)
| Market Cap | 70.56B |
| Revenue (ttm) | 27.74B |
| Net Income (ttm) | -20.11B |
| Shares Out | 31.09M |
| EPS (ttm) | -660.00 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 188,211 |
| Average Volume | 111,210 |
| Open | 2,400.00 |
| Previous Close | 2,400.00 |
| Day's Range | 2,265.00 - 2,400.00 |
| 52-Week Range | 2,265.00 - 7,335.00 |
| Beta | 1.07 |
| RSI | 34.56 |
| Earnings Date | Mar 21, 2025 |